Search research articles
Contact Us
Filters
Showing results (301-310 of 315) with videos related to
Page
of 32
Sort By:
The Cancer Journal From Scientific American
|
May 1, 1995
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease
P M Mauch, L A Kalish, K C Marcus, et al.
Blood
|
February 1, 1982
Histologic progression in non-Hodgkin's lymphoma
S M Hubbard, B A Chabner, V T DeVita, et al.
Leukemia & Lymphoma
|
March 17, 2012
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
Lale Kostakoglu, Heiko Schöder, Jeffrey L Johnson, et al.
The American Journal of Medicine
|
March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity
E Frei, R H Blum, S W Pitman, et al.
Cancer
|
March 26, 2004
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251
David A Rizzieri, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning
C L Cameron, D Cella, J E Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909
Lloyd E Damon, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study
M Perloff, L Norton, A H Korzun, et al.
Haematologica
|
December 3, 2011
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype
Wyndham H Wilson, Sin-Ho Jung, Pierluigi Porcu, et al.
Blood
|
March 1, 2011
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET
David J Straus, Jeffrey L Johnson, Ann S LaCasce, et al.
Page
of 32
Search research articles
Search
Showing results (301-310 of 315) with videos related to
Sort By:
Page
of 32
The Cancer Journal From Scientific American
|
May 1, 1995
Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease
P M Mauch, L A Kalish, K C Marcus, et al.
Blood
|
February 1, 1982
Histologic progression in non-Hodgkin's lymphoma
S M Hubbard, B A Chabner, V T DeVita, et al.
Leukemia & Lymphoma
|
March 17, 2012
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
Lale Kostakoglu, Heiko Schöder, Jeffrey L Johnson, et al.
The American Journal of Medicine
|
March 1, 1980
High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity
E Frei, R H Blum, S W Pitman, et al.
Cancer
|
March 26, 2004
Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251
David A Rizzieri, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association
|
February 24, 2001
Persistent symptoms among survivors of Hodgkin's disease: an explanatory model based on classical conditioning
C L Cameron, D Cella, J E Herndon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 18, 2009
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909
Lloyd E Damon, Jeffrey L Johnson, Donna Niedzwiecki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1996
Postsurgical adjuvant chemotherapy of stage II breast carcinoma with or without crossover to a non-cross-resistant regimen: a Cancer and Leukemia Group B study
M Perloff, L Norton, A H Korzun, et al.
Haematologica
|
December 3, 2011
A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype
Wyndham H Wilson, Sin-Ho Jung, Pierluigi Porcu, et al.
Blood
|
March 1, 2011
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET
David J Straus, Jeffrey L Johnson, Ann S LaCasce, et al.
Page
of 32